Interesting comments from an “agitated” Scott Boras this evening, as he told FOX Sports’ Ken Rosenthal via phone that MLB is wrong to enter into relationships with suppliers of performance-enhancing drugs and that the Anthony Bosch situation sets a dangerous precedent:
“The integrity of the game is only partially served when a known pusher is exonerated, when the genesis of this entire problem is now given a forum and compensation and is not behind bars for the distribution and promoting the use of illegal drugs not only to baseball players, but all members of the sporting community and youth,” Boras said.
“Until we rectify that problem we have not addressed the central issue of eradicating PEDs from professional sports. We have to have legislation; we have to have very clear authority and prosecution of these individuals.
“If these individuals go free, it promotes behavior to create processes to distribute PEDs knowing the league’s focus is on the players not on the distributors of drugs.”
It’s no surprise to hear Boras — the agent — be on the side of the player, and tonight’s comments aren’t far off from what he said back in August when it was first reported that MLB had cut a deal with Bosch. Still, as he often does, Boras has a way of making you think. And it’s hard to shake the notion that in a general sense, MLB’s priorities were out of whack.
Phillies outfielder Tyler Goeddel was included in Wednesday’s starting lineup against the Nationals. It’s notable because it’s only his eighth start in August. The Phillies selected Goeddel from the Rays in the Rule 5 draft during the winter, which means the club has had to keep him on its 25-man roster all season. If the club didn’t, it would have had to offer Goddel back to the Rays.
Goeddel is by no means a top prospect, but the Phillies deemed him worthy enough of taking a year-long 25-man roster spot, which are quite valuable. And the rebuilding Phillies aren’t exactly fighting for a playoff spot, so why not play him?
As Matt Gelb of the Philadelphia Inquirer reports, manager Pete Mackanin asked, “What’s the point?” in regards to starting Goeddel. Mackanin said, “I’ve seen enough of Goeddel to know. We’ve kept him this long and we’re going to keep him and we’ll see where we go next year with him. I don’t see a need to play him, especially after he hasn’t played so much.”
That seems like circular logic. You don’t see a need to play him because he hasn’t played much. Well, maybe if you played him more often, you’d see a reason?
In fairness, Goeddel hasn’t exactly torn the cover off the ball, putting up a .191/.250/.296 triple-slash line in 217 plate appearances. But the Phillies have chosen to play utilityman Cody Asche and journeyman Jimmy Paredes (“an extra player,” according to Mackanin), who both don’t figure to be in the Phillies’ future plans. Goeddel is only 23 years old. In May, when he was starting regularly, he posted a .794 OPS.
This isn’t a roster blunder on the Ruben Amaro, Jr. scale, but it’s a very odd way to handle a Rule-5 player for a rebuilding team.
Diamondbacks pitcher Shelby Miller returned to the majors on Wednesday after a stint of about a month and a half in the minor leagues. The right-hander had compiled an ugly 2-9 record and a 7.14 ERA over 14 big league starts along with a finger injury and the minor league demotion.
On Wednesday afternoon against the Giants at AT&T Park, Miller still got the loss, but he gave up only two runs on six hits and a walk with three strikeouts in three innings. It’s the fifth time in 15 starts he gave up two or fewer runs. Opposing starter Matt Moore, who nearly authored a no-hitter his last time out, was just a little bit better, limiting the D-Backs’ offense to a lone run in 5 1/3 innings. The Giants ultimately won 4-2.
You may recall Miller was part of the trade that forced the Diamondbacks to send Ender Inciarte, Aaron Blair, and 2015 No. 1 overall pick Dansby Swanson to the Braves. It’s a trade that chief baseball officer Tony La Russa defended as recently as last week.